# LAAI (Loan Artificial Intelligence Corp.) - SEC EDGAR Financial Statements

> Loan Artificial Intelligence Corp. reported $0 in revenue and a net loss of $79K for the trailing twelve months ended September 30, 2026.

- Canonical: https://convexityos.com/fundamentals/LAAI
- Markdown: https://convexityos.com/fundamentals/LAAI.md
- SEC CIK: 0001594968
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001594968&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $0 | Sep 30, 2026 |
| Operating Income | TTM | -$79K | Operating profit |
| Net Income | TTM | -$79K | GAAP bottom line |
| Diluted EPS | TTM | -$0.17 | Split-adjusted |
| Free Cash Flow | TTM | -$53K | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $79K | $53K | $57K | $42K |
| **Operating Income** | -$79K | -$53K | -$57K | -$42K |
| **EBITDA** | -$79K | -$53K | -- | -- |
| Income Before Tax | -$79K | -$53K | -$49K | $2.12M |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| **Net Income** | -$79K | -$53K | -$49K | $2.12M |
| Basic EPS | -$0.17 | -$0.12 | $0.00 | -$0.04 |
| **Diluted EPS** | -$0.17 | -$0.12 | $0.00 | $0.01 |
| Basic Shares Outstanding | 454.4K | 454.4K | 166.4M | 57.1M |
| Diluted Shares Outstanding | 454.4K | 454.4K | 166.4M | 57.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $18K | $20K | $8.6K | $32K | $33K | $7.9K | $6.4K | $16K |
| **Operating Income** | -$18K | -$20K | -$8.6K | -$32K | -$33K | -$7.9K | -$6.4K | -$16K |
| **EBITDA** | -- | -- | -$8.6K | -$32K | -$33K | -$7.9K | -$6.4K | -$16K |
| Income Before Tax | -$18K | -$20K | -$8.6K | -$32K | -$33K | -$7.9K | -$6.4K | -$16K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$18K | -$20K | -$8.6K | -$32K | -$33K | -$7.9K | -$6.4K | -$16K |
| Basic EPS | -$0.04 | -$0.04 | -$0.02 | -- | -$0.07 | -$0.02 | -$0.01 | -- |
| **Diluted EPS** | -$0.04 | -$0.04 | -$0.02 | -- | -$0.07 | -$0.02 | -$0.01 | -- |
| Basic Shares Outstanding | 454.4K | 454.4K | 454.4K | -- | 454.4K | 454.4K | 454.4K | -- |
| Diluted Shares Outstanding | 454.4K | 454.4K | 454.4K | -- | 454.4K | 454.4K | 454.4K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $0 | $0 | $754 |
| **Cash & Short-Term Investments** | -- | $0 | $0 | $754 |
| **Total Current Assets** | $0 | $0 | $0 | $754 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 |
| **Total Assets** | $0 | $0 | $0 | $754 |
| **Total Current Liabilities** | $190K | $110K | $58K | $9.5K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $190K | $110K | $58K | $9.5K |
| Common Stock | $454 | $454 | $364K | $58K |
| Retained Earnings | -$10.58M | -$10.50M | -$10.45M | -$10.40M |
| **Total Stockholders' Equity** | -$190K | -$110K | -$58K | -$8.8K |
| Total Equity | -$190K | -$110K | -$58K | -$8.8K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Cash & Short-Term Investments** | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Total Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Current Liabilities** | $236K | $219K | $198K | $190K | $157K | $125K | $117K | $110K |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $236K | $219K | $198K | $190K | $157K | $125K | $117K | $110K |
| Common Stock | $454 | $454 | $454 | $454 | $454 | $364K | $364K | $454 |
| Retained Earnings | -$10.63M | -$10.61M | -$10.59M | -$10.58M | -$10.55M | -$10.52M | -$10.51M | -$10.50M |
| **Total Stockholders' Equity** | -$236K | -$219K | -$198K | -$190K | -$157K | -$125K | -$117K | -$110K |
| Total Equity | -$236K | -$219K | -$198K | -$190K | -$157K | -$125K | -$117K | -$110K |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$79K | -$53K | -$49K | $2.12M |
| Depreciation & Amortization | $0 | $0 | -- | -- |
| **Operating Cash Flow** | -$53K | -$31K | -$40K | -$8.8K |
| Capital Expenditure | $0 | $0 | -- | -- |
| **Free Cash Flow** | -$53K | -$31K | -- | -- |
| **Investing Cash Flow** | $0 | $0 | -$7.7K | $0 |
| **Financing Cash Flow** | $53K | $31K | $47K | $9.5K |
| **Net Change in Cash** | $0 | $0 | -$754 | $754 |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$18K | -$20K | -$8.6K | -$32K | -$33K | -$7.9K | -$6.4K | -$16K |
| Depreciation & Amortization | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| **Operating Cash Flow** | -$15K | -$3.0K | -$38K | -$30K | -$21K | -$1.5K | -$560 | -$7.3K |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -- | -$7.3K |
| **Financing Cash Flow** | $15K | $3.0K | $38K | $30K | $21K | $1.5K | $560 | $7.3K |
| **Net Change in Cash** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -- | -- | -- | 281602.7% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.08x |
| Quick Ratio | -- | 0.00x | 0.00x | 0.08x |
| **Net Income Growth (YoY)** | -- | -- | -102.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Quick Ratio | -- | -- | -- | -- | -- | 0.00x | 0.00x | 0.00x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -221.5% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
